Trial Profile

To Evaluate IAH0968 in Combination With CAPEOX in a Phase II/III Clinical Study of HER2-positive Metastatic Colorectal Cancer

Status: Recruiting

Phase of Trial: Phase II/III

Latest Information Update: 31 Jul 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs IAH 0968 (Primary) ; Capecitabine; Oxaliplatin
Indications Colorectal cancer; Solid tumours
Focus Therapeutic Use
Sponsors SUNHO (China) BioPharmaceutical

Most Recent Events

31 Jul 2023 Last checked against ClinicalTrials.gov: US National Institutes of Health record.
24 Jul 2023 Status changed from not yet recruiting to recruiting.
09 Jan 2023 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com